4.7 Article

Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

期刊

MOLECULAR PHARMACEUTICS
卷 15, 期 11, 页码 5263-5276

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.8b00766

关键词

glioblastoma; temozolomide; drug delivery; polymer-drug conjugate; poly(methacryloyloxyethyl phosphorylcholine)

资金

  1. National Institutes of Health [R21 CA167674]
  2. National Science Foundation Graduate Research Fellowship [1451512]

向作者/读者索取更多资源

A series of polymer drug conjugates based on 2-methacryloyloxyethyl phosphorylcholine (MPC) was prepared with the glioblastoma drug temozolomide (TMZ) as pendent groups. Random and block copolymers were synthesized by reversible addition fragmentation chain-transfer (RAFT) polymerization using a TMZ-containing methacrylate monomer. The solution properties of the polyMPC-TMZ copolymers were investigated by dynamic light scattering and transmission electron microscopy, revealing well-defined nanostructures from the block copolymers. Conjugation of TMZ to polyMPC enhanced drug stability, with decomposition half-life values ranging from 2- to 19-times longer than that of free TMZ. The cytotoxicity of polyMPC TMZ was evaluated in both chemosensitive (U87MG) and chemoresistant (T98G) glioblastoma cell lines. Furthermore, the polyMPC TMZ platform was expanded considerably by the preparation of redox-sensitive polyMPC-TMZ copolymers utilizing disulfides as the polymer-to-drug linker.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据